Zobrazeno 1 - 10
of 59
pro vyhledávání: '"HIROMICHI OSHIRO"'
Autor:
Kohei Mizuta, Hiromichi Oshiro, Ryo Katsuki, Yuichi Tsuha, Yusuke Aoki, Yasunori Tome, Kotaro Nishida
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Little is known on how denosumab reduces skeletal-related events (SREs) by bone metastases from solid tumors. We sought to evaluate the effect of denosumab administration in patients with bone metastases from solid tumors. Methods
Externí odkaz:
https://doaj.org/article/4acd03576bce454da3ada024cd90dfdc
Publikováno v:
BMC Musculoskeletal Disorders, Vol 24, Iss 1, Pp 1-5 (2023)
Abstract Background 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) is useful for assessing location, metastasis, staging, and recurrence of malignant tumors. Tenosynovial giant cell tumor (TSGCT) is a benign
Externí odkaz:
https://doaj.org/article/b57ef7f00cb540ee8b35f7c2e619f85b
Autor:
Kotaro Higa, Fuminari Uehara, Chinatsu Azuma, Hiromichi Oshiro, Yasunori Tome, Kotaro Nishida
Publikováno v:
Journal of Orthopaedic Surgery, Vol 31 (2023)
Background Arthroscopic resection of tenosynovial giant cell tumor (TS-GCT) presents favorable outcomes. However, there are reportedly higher recurrence rates in patients who had incomplete resection. To minimize incomplete resection, we established
Externí odkaz:
https://doaj.org/article/205cc3683fc843019b21352384c7c849
Autor:
Hiromichi Oshiro, Yasunori Tome, Kentaro Miyake, Takashi Higuchi, Norihiko Sugisawa, Fuminori Kanaya, Kotaro Nishida, Robert M. Hoffman
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract In order to identify more effective therapy for recalcitrant osteosarcoma, we evaluated the efficacy of an mTOR-VEGFR inhibitor combination on tumor growth in a unique osteosarcoma patient-derived orthotopic xenograft (PDOX) mouse model deri
Externí odkaz:
https://doaj.org/article/0b91a6a245e14c3595b158c6ec10aae3
Autor:
Takashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, Hiromichi Oshiro, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
Publikováno v:
Translational Oncology, Vol 12, Iss 9, Pp 1257-1263 (2019)
Chemotherapy-resistant osteosarcoma is a recalcitrant disease. It is a frequent cause of death to the patients who are usually adolescent or young adults. The goal of the present study was to determine the efficacy of the combination of olaratumab (O
Externí odkaz:
https://doaj.org/article/6487ece1c28149e49aa1642a550c0e78
Autor:
Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Kentaro Miyake, Norihiko Sugisawa, Yuki Katsuya, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Ming Zhao, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M Hoffman
Publikováno v:
Translational Oncology, Vol 12, Iss 4, Pp 640-645 (2019)
The goal of the present study was to determine the efficacy of osimertinib (AZD9291), a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor for the treatment of aggressive EGFR-mutant non-small cell lung cancer (NSCLC),
Externí odkaz:
https://doaj.org/article/2752c71a9e05436fb25ab8088b3e6cfc
Autor:
HIROMICHI OSHIRO, KOHEI MIZUTA, YUICHI TSUHA, YUSUKE AOKI, RYO KATSUKI, YASUNORI TOME, KOTARO NISHIDA
Publikováno v:
Cancer Diagnosis & Prognosis; Mar/Apr2024, Vol. 4 Issue 2, p141-146, 6p
Publikováno v:
Molecular and Clinical Oncology. 18
Autor:
Yuichi Tsuha, Hiromichi Oshiro, Kohei Mizuta, Yusuke Aoki, Tomoko Tamaki, Naoki Wada, Yasunori Tome, Kotaro Nishida
Publikováno v:
Medicine; 12/22/2023, Vol. 102 Issue 51, p1-5, 5p
Autor:
Yuichi Tsuha, Hiromichi Oshiro, Kohei Mizuta, Tomoko Tamaki, Yasunori Tome, Naoki Wada, Kotaro Nishida
Publikováno v:
Molecular and Clinical Oncology. 18